Publications
Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium. Applied and Environmental Microbiology, 82, 6109-6119. 2016_extending_crispr-cas9_technology_from_genome_editing_to_transcriptional_engineering_in_the_genus_clostridium.pdf
. (2016). Fedbatch operation using Clostridium acetobutylicum suspension culture as biocatalyst for enhancing hydrogen production. Biotechnology Progress, 19, 383-388.
. (2003). Functional expression of a single-chain antibody fragment against human epidermal growth factor receptor 2 (HER2) in Escherichia coli. Journal of Industrial Microbiology & Biotechnology, 41, 947-956.
. (2014). Genetic manipulation to identify limiting steps and develop strategies for high-level expression of penicillin acylase in Escherichia coli. Biotechnology and Bioengineering, 63, 263-272. 1999_genetic_manipulation_to_identify_limiting_steps_and_develop_strategies_for_high-level_expression_of_penicillin_acylase_in_escherichia_coli.pdf
. (1999). Genetic strategies to enhance penicillin acylase production in Escherichia coli. Enzyme and Microbial Technology, 27, 766-773.
. (2000). . (2016). . (2019). Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium. Scientific Reports, 6. 2016_harnessing_heterologous_and_endogenous_crispr-cas_machineries_for_efficient_markerless_genome_editing_in_clostridium.pdf
. (2016). Heterologous expression of lipase in Escherichia coli is limited by folding and disulfide bond formation. Applied Microbiology and Biotechnology, 81, 79-87.
. (2008). Heterologous production of 3-hydroxyvalerate in engineered Escherichia coli. Metabolic Engineering, 61, 141-151. 2020_heterologous_production_of_3-hydroxyvalerate_in_engineered_escherichia_coli_.pdf
. (2020). High-level extracellular production of penicillin acylase by genetic engineering of Escherichia coli. Journal of Chemical Technology and Biotechnology, 76, 1030-1037.
. (2001). High-level gene expression for recombinant penicillin acylase production using the araB promoter system in Escherichia coli. Biotechnology Progress, 22, 1518-1523.
. (2006). High-level heterologous production of propionate in engineered Escherichia coli. Biotechnology and Bioengineering, 117, 1304-1315 . 2020_high-level_heterologous_production_of_propionate_in_engineered_escherichia_coli.pdf
. (2020). Immunosuppression Involving Soluble CD83 Induces Tolerogenic Dendritic Cells That Prevent Cardiac Allograft Rejection. Transplantation, 90, 1145-1156.
(2010). Improved biological activity of a single chain antibody fragment against human epidermal growth factor receptor 2 (HER2) expressed in the periplasm of Escherichia coli. Protein Expression and Purification, 116, 66-74.
. (2015). Improved Draft Genome Sequence of Clostridium pasteurianum Strain ATCC 6013 (DSM 525) Using a Hybrid Next-Generation Sequencing Approach. Genome announcements, 2, e00790-14.
. (2014). Improving production of penicillin acylase in Escherichia coli via efficient DegP-mediated processing of precursors in periplasm. Process Biochemistry, 37, 23-30.
. (2001). In vivo monitoring and alleviation of extracytoplasmic stress to recombinant protein overproduction in the periplasm of Escherichia coli. Biochemical Engineering Journal, 42, 13-19.
. (2008). Integrated development of an effective bioprocess for extracellular production of penicillin G acylase in Escherichia coli and its subsequent one-step purification. Journal of Biotechnology, 161, 19-26.
(2012). Integrated strain engineering and bioprocessing strategies for high-level bio-based production of 3-hydroxyvalerate in Escherichia coli. Applied Microbiology and Biotechnology, 104, 5259-5272. 2020_integrated_strain_engineering_and_bioprocessing_strategies_for_high-level_bio-based_production_of_3-hydroxyvalerate_in_escherichia_coli.pdf
. (2020).